4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-26-048321
Options or other derivatives
- CEO acquired 0 shares (option exercise)
- CEO acquired 7,599 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Pershing Edward CEO | 2026-10-23 | Option exercise · 8% Unsecured Convertible Promissory Note | −0 | D | |||
| Pershing Edward CEO | 2026-10-23 | Option exercise · Series D-1 Convertible Preferred Stock | +7,599 | 3,006,133 | D | ||
Loading xslF345X06/ownership.xml…